Contraindicated (1)pentobarbital will reduce the level or effect of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with sturdy CYP3A4 inducers may lead to reduced serum concentrations and lack of antimalarial efficacy pentobarbital will re